$MRKR
Marker Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.18
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMarker Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is MRKR up today? It is at $1.18 (+0.00%). See the catalyst behind the move, real-time alerts the moment MRKR spikes, and full due diligence on MRKR — key stats, earnings, dilution and insider activity. Free.
Be first to know when $MRKR makes an unusual move. Create a free account to track $MRKR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MRKR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MRKR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMarker Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
New Enterprise Associates 16, L.P. Beneficial Owner (10%) | Bought (open market) | +554K 3.3% of company | added 52% | 1.63M | $1.8M at $3.20 | Dec 23, 24 |
Elms Steve Director | Bought (open market) | +11K 0.07% of company | added 3.5% | 325K | $35K at $3.20 | Dec 23, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MRKR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MRKR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MRKR last traded at $1.18, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Marker Therapeutics, Inc. Common Stock (MRKR) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MRKR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MRKR 0 times in the last 30 days.
MRKR (Marker Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $20M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MRKR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MRKR discussion
Sign in to ask a question or join the discussion.